Raphael Pharmaceutical (RAPH) Notes Payables (2020 - 2025)

Raphael Pharmaceutical has disclosed Notes Payables across 5 years of filings, most recently posting $34000.0 for Q4 2025.

• Notes Payables for Q4 2025 came in at $34000.0, down 85.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $34000.0 (down 85.09% YoY), and the FY2025 annual result was $34000.0, down 85.09% from the prior year.
• Notes Payables came in at $34000.0 for Q4 2025 at Raphael Pharmaceutical, down from $755000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $755000.0 in Q3 2025 to a low of $3000.0 in Q4 2022.
• The 4-year median for Notes Payables is $39500.0 (2023), against an average of $117666.7.
• Across the five-year window, Notes Payables jumped 1166.67% in 2023 and sank 85.09% in 2025, its largest moves.
• Raphael Pharmaceutical's Notes Payables stood at $3000.0 in 2022, then surged by 1166.67% to $38000.0 in 2023, then jumped by 500.0% to $228000.0 in 2024, then tumbled by 85.09% to $34000.0 in 2025.
• The last three Notes Payables figures came in at $34000.0 (Q4 2025), $755000.0 (Q3 2025), and $41000.0 (Q2 2025), per Business Quant data.